Activists: Higher All-Time Highs, Please
Sometimes, great isn’t good enough. (00:21) Jason Moser and Mary Long discuss T-Mobile’s latest purchase and why Elliott Management has beef with a company that’s trading at all-time highs. Then, at...
28 Maj 202428min
Finding “Home Run” Investments
Venture capitalists don’t mind strike-outs, so long as they get their home runs. What can stock investors learn from that approach? Ricky Mulvey talks with Ilya Strebulaev and Alex Dang, co-authors ...
26 Maj 202437min
The Movies’ Market Correction
In 2018, the U.S. box office grossed almost $12 billion. This year, it’s expected to bring in closer to $8 billion. What’s eating the silver screen? Catie Peiper, the Fool’s resident entertainment ex...
25 Maj 202419min
Nvidia, Target & The Mailbag
AI continues to float Nvidia’s boat, and it's helping an unlikely old school name in tech. (00:21) Jason Moser and Bill Mann discuss: - Nvidia’s blowout quarter and upcoming stock split. - Why buy-no...
24 Maj 202440min
Nvidia Rolls On
The tech giant continues to crush analysts’ lofty expectations. (00:20) Asit Sharma joins Ricky Mulvey to discuss the boom of Nvidia’s data center business, future growth stories for the company, and ...
23 Maj 202426min
Tight Budgets Come for Target
Just how resilient is resilient? (00:21) Jason Moser and Mary Long take a look at Target earnings, the “resilient consumer,” and new rules for the Buy Now, Pay Later industry. Then, at (14:47), Matt...
22 Maj 202432min
What's on Jamie Dimon's Mind?
A lot, actually. (00:21) Bill Mann and Ricky Mulvey discuss JPMorgan’s investor day and CEO Jamie Dimon’s thoughts on stock buybacks and inflation. They also talk about the shift toward fast-casual d...
21 Maj 202432min
A New Name in Weight-Loss Drugs
Novo Nordisk and Eli Lilly have soared on GLP-1 weight-loss drugs – now Hims & Hers is trying to get in on the action with a more available and affordable option. (00:21) Asit Sharma and Dylan Lewis...
20 Maj 202426min
